Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1755)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4172)
  2. Weinberg Fellows (2756)
  3. Hematologic Malignancies, Division of (2492)
  4. Solid Tumor Oncology Division (2422)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (343)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Large-scale TCR deep sequencing reveals a T cell diversity bottleneck with post-transplant cyclophosphamide with implications for efficacy and toxicity: Results of the BMT-CTN 1801 study
    Meeting Abstract

    Kean, L.; Siegel, S.; Schmalz, J.; Bien, S.; DeWolf, S.; Dong, J.; Scheffey, D.; Sanders, C.; Robins, H.; Applegate, K.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Localized molecular chaperone synthesis maintains neuronal dendrite proteostasis
    Journal Article

    Alecki, C.; Rizwan, J.; Le, P.; Jacob-Tomas, S.; Comaduran, M. F.; Verbrugghe, M.; Xu, J. M. S.; Minotti, S.; Lynch, J.; Biswas, J.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis
    Journal Article

    Andersen, M. Jr; Fernandez Turizo, M. J.; Dodge, L. E.; Hsu, C.; Barnum, K.; Berry, J.; Zwicker, J. I.; Patell, R.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Efficacy of pirtobrutinib in BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Phase 1/2 BRUIN study results by prior BCL2-inhibitor therapy
    Meeting Abstract

    Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
    Oncology Research and Treatment (2024)

    Fulltext@MSK | Save
  • Pirtobrutinib in relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients with prior cBTKi: Updated safety and efficacy including high-risk subgroup analyses from the phase 1/2 BRUIN study
    Meeting Abstract

    Cohen, J. B.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Cheah, C. Y.; Eyre, T. A.; Ujjani, C. S.; Koh, Y.; Kim, W. S.; Nasta, S. D.; more...
    Oncology Research and Treatment (2024)

    Fulltext@MSK | Save
  • Pirtobrutinib in heavily pre-treated richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study
    Meeting Abstract

    Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffman, M. S.; Coombs, C. C.; Lamanna, N.; Shuo, M. A.; Jagadeesh, D.; Munir, T.; more...
    Oncology Research and Treatment (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors
    Meeting Abstract

    Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save